Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

by Steven E. Coutre, Ian W. Flinn, Sven de Vos, Jacqueline C. Barrientos, Marshall T. Schreeder, Nina D. Wagner-Johnson, Jeff P. Sharman, Thomas E. Boyd, Nathan Fowler, Lyndah Dreiling, Yeonhee Kim, Siddhartha Mitra, Kanti Rai, John P. Leonard, Richard R. Furman
Published 2018-06-01

STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial

by Matthew J. Reilley, Patricia McCoon, Carl Cook, Paul Lyne, Razelle Kurzrock, Youngsoo Kim, Richard Woessner, Anas Younes, John Nemunaitis, Nathan Fowler, Michael Curran, Qinying Liu, Tianyuan Zhou, Joanna Schmidt, Minji Jo, Samantha J. Lee, Mason Yamashita, Steven G. Hughes, Luis Fayad, Sarina Piha-Paul, Murali V. P. Nadella, Xiaokun Xiao, Jeff Hsu, Alexey Revenko, Brett P. Monia, A. Robert MacLeod, David S. Hong
Published 2018-11-01

Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy

by Tommy Sheu, MD, Sarah A. Milgrom, MD, Therese Y. Andraos, MD, Jillian R. Gunther, MD, PhD, Linda Chi, MD, Loretta Nastoupil, MD, Nathan Fowler, MD, Yasuhiro Oki, MD, Michelle A. Fanale, MD, Luis E. Fayad, MD, Fredrick Hagemeister, MD, Sattva S. Neelapu, MD, L. Jeffrey Medeiros, MD, Chitra Hosing, MD, Yago Nieto, MD, PhD, Sairah Ahmed, MD, Amin M. Alousi, MD, Bouthaina Dabaja, MD, Chelsea C. Pinnix, MD, PhD
Published 2018-10-01